Compare AMPH & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | CMP |
|---|---|---|
| Founded | 1996 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.8M | 1.0B |
| IPO Year | 2005 | 2003 |
| Metric | AMPH | CMP |
|---|---|---|
| Price | $17.21 | $29.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $28.38 | $21.50 |
| AVG Volume (30 Days) | 568.2K | ★ 693.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.14 | ★ 0.73 |
| Revenue | ★ $719,887,000.00 | N/A |
| Revenue This Year | $6.90 | N/A |
| Revenue Next Year | $4.64 | $1.29 |
| P/E Ratio | $120.25 | ★ $40.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.76 | $16.40 |
| 52 Week High | $31.26 | $32.39 |
| Indicator | AMPH | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 33.88 | 63.62 |
| Support Level | $17.03 | $20.83 |
| Resistance Level | $24.16 | N/A |
| Average True Range (ATR) | 0.86 | 1.96 |
| MACD | -0.60 | 0.23 |
| Stochastic Oscillator | 7.21 | 65.95 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.